Vemurafenib in patients with Erdheim-Chester disease (ECD) and Langerhans cell histiocytosis (LCH) harboring BRAF(V600) mutations: A cohort of the histology-independent VE-BASKET study Meeting Abstract


Authors: Diamond, E. L.; Subbiah, V.; Lockhart, C.; Blay, J. Y.; Faris, J. E.; Puzanov, I.; Chau, I.; Raje, N. S.; Wolf, J. S.; Erinjeri, J.; Torrisi, J.; Ulaner, G.; Lacouture, M.; Robson, S.; Makrutzki, M.; Elez, E.; Tabernero, J.; Abdel-Wahab, O.; Baselga, J.; Hyman, D. M.
Abstract Title: Vemurafenib in patients with Erdheim-Chester disease (ECD) and Langerhans cell histiocytosis (LCH) harboring BRAF(V600) mutations: A cohort of the histology-independent VE-BASKET study
Meeting Title: 58th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 128
Issue: 22
Meeting Dates: 2016 Dec 3-6
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2016-12-02
Language: English
ACCESSION: WOS:000394446804123
PROVIDER: wos
DOI: 10.1182/blood.V128.22.480.480
Notes: Meeting Abstract: 480 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jean Marie Torrisi
    16 Torrisi
  2. Mario E Lacouture
    457 Lacouture
  3. Gary Ulaner
    147 Ulaner
  4. David Hyman
    354 Hyman
  5. Joseph Patrick Erinjeri
    203 Erinjeri
  6. Eli Louis Diamond
    204 Diamond
  7. Jose T Baselga
    484 Baselga